• Latest Posts

TROD’s MedTech for Prostate Cancer Kills Tumor Cells with Radio Waves

Alphabody Platform for Cancer Draws in €260M Discovery Deal with MSD

64 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives

Finally! Galapagos New Mystery Partner to Replace AbbVie Revealed in €2Bn Deal

Ablynx Top Trumps: Adding Danish Diabetes Giant Novo Nordisk to its Biotech Deck

Curetis Molecular Diagnostics IPO Exceeds Expectations

ADVERTISEMENT

The 10 Hottest Bioincubators in Europe

Last exclusive interview from #BIO-Europe 2015: Andre Hoekema, SVP Corporate Development of Galapagos

ERRATUM: Celyad’s US patent on TCR-deficient allogeneic CAR-T cells

Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries

For when it actually is Lupus: New Autoimmune Crisis Drug reaches Human Trials

Ablynx richly rewarded for MSD’s Nanobody Proof in Immuno-Oncology

ADVERTISEMENT